Publications by authors named "Steven D Forsythe"

Claim this Profile
S
Synergistic Inhibition of PI3K and HSP90 Enhanced Antitumorigenic Efficacy in Adrenocortical Carcinoma.
Prachi Mishra, Brieann Sobieski, Dipranjan Laha, Steven D Forsythe, Min Shen

Res Sq· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biofabrication of pheochromocytoma and paraganglioma tumor organoids and assessment of response to systemic therapy.
Richard A Erali, Steven D Forsythe, Cecilia R Schaaf, Nicholas Edenhoffer, William Meeker

Sci Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Genomic Topography of Appendiceal Cancers: Our Current Understanding, Clinical Perspectives, and Future Directions.
Daniel J Gironda, Richard A Erali, Steven D Forsythe, Ashok K Pullikuth, Rui Zheng-Pywell

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiple Epigenetic Mechanisms Functionally Cooperate to Silence Expression of Somatostatin Receptor Type 2 in Pancreatic Neuroendocrine Tumors.
James P Madigan, Stephen G Andrews, Rivka B Farrell, Steven D Forsythe, Rupali Sharma

bioRxiv· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of the Tumor Microenvironment in Gastroenteropancreatic Neuroendocrine Tumors.
Srujana V Yellapragada, Steven D Forsythe, James P Madigan, Samira M Sadowski

Int J Mol Sci· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TGFβ in Pancreas and Colorectal Cancer: Opportunities to Overcome Therapeutic Resistance.
Allan M Johansen, Steven D Forsythe, Callum T McGrath, Grayson Barker, Hugo Jimenez

Clin Cancer Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancing the Efficacy of HIPEC Through Bromelain: A Preclinical Investigation in Appendiceal Cancer.
Nadeem Wajih, Richard A Erali, Steven D Forsythe, Cecilia R Schaaf, Perry Shen

Ann Surg Oncol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multifaceted modeling of small intestinal neuroendocrine tumors.
Stephen Gabriel Andrews, Steven D Forsythe, James P Madigan, Samira Mercedes Sadowski

Endocr Oncol· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing Patient-Derived Organoids in the Management of Colorectal Cancer with Peritoneal Metastases: A Review of Current Literature.
Richard A Erali, Steven D Forsythe, Daniel J Gironda, Cecilia R Schaaf, Nadeem Wajih

J Gastrointest Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cisplatin exhibits superiority over MMC as a perfusion agent in a peritoneal mesothelioma patient specific organoid HIPEC platform.
Steven D Forsythe, Richard A Erali, Nicholas Edenhoffer, William Meeker, Nadeem Wajih

Sci Rep· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Models in Pancreatic Neuroendocrine Neoplasms: Current Perspectives and Future Directions.
Steven D Forsythe, Tracey Pu, Stephen G Andrews, James P Madigan, Samira M Sadowski

Cancers (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center.
Cristian D Valenzuela, Ian B Solsky, Richard A Erali, Steven D Forsythe, Christopher W Mangieri

Ann Surg Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Sarcoma Organoids: Neutralizing the Word "Rare" in Rare Cancers.
Steven D Forsythe, Hemamylammal Sivakumar, Richard A Erali, Aleksander Skardal, Konstantinos I Votanopoulos

Ann Surg Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications.
Steven D Forsythe, Hemamylammal Sivakumar, Richard A Erali, Nadeem Wajih, Wencheng Li

Ann Surg Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of immune enhanced organoids in modeling personalized Merkel cell carcinoma research.
Steven D Forsythe, Richard A Erali, Preston Laney, Hemamylammal Sivakumar, Wencheng Li

Sci Rep· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study.
Steven D Forsythe, Richard A Erali, Shyama Sasikumar, Preston Laney, Ethan Shelkey

Clin Cancer Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cell Viability Assays in Three-Dimensional Hydrogels: A Comparative Study of Accuracy.
Anthony J Dominijanni, Mahesh Devarasetty, Steven D Forsythe, Konstantinos I Votanopoulos, Shay Soker

Tissue Eng Part C Methods· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bio-instructive hydrogel expands the paracrine potency of mesenchymal stem cells.
Norman M Drzeniek, Andrea Mazzocchi, Stephan Schlickeiser, Steven D Forsythe, Guido Moll

Biofabrication· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Modeling of the Tumor Microenvironment in Tumor Organoids.
Mahesh Devarasetty, Steven D Forsythe, Ethan Shelkey, Shay Soker

Tissue Eng Regen Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized Identification of Optimal HIPEC Perfusion Protocol in Patient-Derived Tumor Organoid Platform.
Steven D Forsythe, Shyama Sasikumar, Omeed Moaven, Hemamylammal Sivakumar, Perry Shen

Ann Surg Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ASO Author Reflections: Patient-Derived Tumor Organoids-A Platform for a Precision Approach for Peritoneal Malignancies.
Steven D Forsythe, Omeed Moaven, Konstantinos I Votanopoulos

Ann Surg Oncol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental Toxin Screening Using Human-Derived 3D Bioengineered Liver and Cardiac Organoids.
Steven D Forsythe, Mahesh Devarasetty, Thomas Shupe, Colin Bishop, Anthony Atala

Front Public Health· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioprinting Cellularized Constructs Using a Tissue-specific Hydrogel Bioink.
Aleksander Skardal, Mahesh Devarasetty, Hyun-Wook Kang, Young-Joon Seol, Steven D Forsythe

J Vis Exp· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis